Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margaret C Frame

Showing results (101-110 of 105) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 105 results.
Cell|April 15, 2021
Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasionEster Gangoso, Benjamin Southgate, Leanne Bradley, et al.
The Journal of Clinical Investigation|July 2, 2010
Epigenetic downregulation of human disabled homolog 2 switches TGF-beta from a tumor suppressor to a tumor promoterAdèle Hannigan, Paul Smith, Gabriela Kalna, et al.
Nature Communications|June 9, 2021
Oncogenic BRAF, unrestrained by TGFβ-receptor signalling, drives right-sided colonic tumorigenesisJoshua D G Leach, Nikola Vlahov, Petros Tsantoulis, et al.
Nature|May 8, 2024
The intrinsic substrate specificity of the human tyrosine kinomeTomer M Yaron-Barir, Brian A Joughin, Emily M Huntsman, et al.
Gastroenterology|October 11, 2020
Targeting DNA Damage Response and Replication Stress in Pancreatic CancerStephan B Dreyer, Rosie Upstill-Goddard, Viola Paulus-Hock, et al.
Pageof 11

Showing results (101-110 of 105) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 105 results.
Cell|April 15, 2021
Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasionEster Gangoso, Benjamin Southgate, Leanne Bradley, et al.
The Journal of Clinical Investigation|July 2, 2010
Epigenetic downregulation of human disabled homolog 2 switches TGF-beta from a tumor suppressor to a tumor promoterAdèle Hannigan, Paul Smith, Gabriela Kalna, et al.
Nature Communications|June 9, 2021
Oncogenic BRAF, unrestrained by TGFβ-receptor signalling, drives right-sided colonic tumorigenesisJoshua D G Leach, Nikola Vlahov, Petros Tsantoulis, et al.
Nature|May 8, 2024
The intrinsic substrate specificity of the human tyrosine kinomeTomer M Yaron-Barir, Brian A Joughin, Emily M Huntsman, et al.
Gastroenterology|October 11, 2020
Targeting DNA Damage Response and Replication Stress in Pancreatic CancerStephan B Dreyer, Rosie Upstill-Goddard, Viola Paulus-Hock, et al.
Pageof 11